Medicus Pharma Ltd.
MDCXWNasdaq
$0.38
↓ -20.8%Jul 17 close · end-of-day
Price
1Y↓ -60.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$11.2M
Enterprise Value
$7.2M
P/E
—
P/S
—
P/B
8.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$51.2M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-3862.7%
ROIC
—
Debt / Equity
1.8
Net Cash
$4.0M
Return 1Y
-64.8%
Company profile
Earnings
MDCXW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.31↓ -26.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$4.7M | -$11.2M | -$34.4M |
| Net income | -$5.3M | -$11.2M | -$47.3M |
| Diluted EPS | -$1.53 | -$1.16 | -$2.74 |
| Operating cash flow | -$4.2M | -$10.2M | -$22.8M |
| Free cash flow | — | — | — |
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$3.6M | -$2.3M | -$3.6M | -$5.1M | -$6.0M | -$15.00 | -$23.2M | -$8.6M |
| Net income | -$3.6M | -$2.3M | -$3.5M | -$5.1M | -$6.2M | -$20.9M | -$15.1M | -$9.0M |
| Diluted EPS | -$0.44 | -$0.24 | -$0.27 | -$0.42 | -$0.43 | -$1.12 | -$0.77 | -$0.31 |
| Operating cash flow | -$2.8M | -$3.1M | -$3.2M | -$3.9M | -$5.5M | -$6.8M | -$6.6M | -$9.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for MDCXW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-08-13 | Quinlan James P.· Chief Financial Officer | Option exercise | 125,000 | $0.81 | $101,250.00 | filing |
| 2025-08-13 | Quinlan James P.· Chief Financial Officer | Option exercise | 20,000 | $2.75 | $55,000.00 | filing |
Latest 2 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.